Stockscreener 앱 받기
34.76
0.20%
-0.07
시간 외 거래:
35.00
0.24
+0.69%
Travere Therapeutics Inc 주식(TVTX)의 최신 뉴스
Squarepoint Ops LLC Grows Position in Travere Therapeutics, Inc. $TVTX - MarketBeat
Frazier Life Sciences Management L.P. Makes New Investment in Travere Therapeutics, Inc. $TVTX - MarketBeat
Birchview Capital LP Trims Stake in Travere Therapeutics, Inc. $TVTX - MarketBeat
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)December 11, 2025 - BioSpace
Trading Systems Reacting to (TVTX) Volatility - news.stocktradersdaily.com
Federated Hermes Inc. Sells 145,110 Shares of Travere Therapeutics, Inc. $TVTX - MarketBeat
Travere Therapeutics (NASDAQ: TVTX) issues 20,300 new-hire RSUs vesting over four years - Stock Titan
742,725 Shares in Travere Therapeutics, Inc. $TVTX Acquired by Marshall Wace LLP - MarketBeat
Ligand Hosts 2025 Investor Day and Introduces 2026 Guidance - GlobeNewswire Inc.
Schroder Investment Management Group Decreases Position in Travere Therapeutics, Inc. $TVTX - MarketBeat
Capital Fund Management S.A. Acquires Shares of 101,406 Travere Therapeutics, Inc. $TVTX - MarketBeat
Travere Therapeutics (NASDAQ:TVTX) CFO Christopher Cline Sells 20,000 Shares - MarketBeat
Panagora Asset Management Inc. Buys 96,062 Shares of Travere Therapeutics, Inc. $TVTX - MarketBeat
Travere Therapeutics CFO Sells 20,000 Shares - TradingView
Loomis Sayles & Co. L P Trims Position in Travere Therapeutics, Inc. $TVTX - MarketBeat
Travere Therapeutics (NASDAQ:TVTX) Is Carrying A Fair Bit Of Debt - 富途牛牛
Legal & General Group Plc Boosts Stake in Travere Therapeutics, Inc. $TVTX - MarketBeat
Travere Therapeutics, Inc. (TVTX) Investigation: Bronstein, Gewir - The National Law Review
Travere Therapeutics (TVTX) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Evercore Healthcare Conference - MarketScreener
The Insider Report: The Dip Was Bought Before the Holidays - Benzinga
Virtus Investment Advisers LLC Buys 9,699 Shares of Travere Therapeutics, Inc. $TVTX - MarketBeat
F m Investments LLC Has $2.78 Million Stock Position in Travere Therapeutics, Inc. $TVTX - MarketBeat
Travere Therapeutics (NASDAQ:TVTX) Downgraded to "Buy" Rating by Wall Street Zen - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review
Is Travere Therapeutics Inc. stock a contrarian buyJuly 2025 Fed Impact & Verified Entry Point Signals - BỘ NỘI VỤ
Bronstein, Gewirtz & Grossman, LLC Is Investigating Travere Thera - The National Law Review
Travere Therapeutics (NASDAQ:TVTX) Reaches New 52-Week HighHere's Why - MarketBeat
HC Wainwright Reiterates "Buy" Rating for Travere Therapeutics (NASDAQ:TVTX) - MarketBeat
Intech Investment Management LLC Cuts Stake in Travere Therapeutics, Inc. $TVTX - MarketBeat
Travere Therapeutics, Inc. $TVTX Shares Bought by Geode Capital Management LLC - MarketBeat
SG Americas Securities LLC Purchases Shares of 31,926 Travere Therapeutics, Inc. $TVTX - MarketBeat
Travere Therapeutics, Inc. 2025 Q3ResultsEarnings Call Presentation (NASDAQ:TVTX) 2025-11-29 - Seeking Alpha
Travere Therapeutics stock hits 52-week high at 37.12 USD By Investing.com - Investing.com Nigeria
Travere Therapeutics stock hits 52-week high at 37.12 USD - Investing.com
TVTX: HC Wainwright Reiterates Buy Rating and Maintains Price Ta - GuruFocus
HC Wainwright & Co. Reiterates Travere Therapeutics (TVTX) Buy Recommendation - Nasdaq
A Look at Travere Therapeutics’s Valuation Following FDA Updates Boosting FILSPARI’s Accessibility and Growth Prospects - Sahm
Travere Therapeutics, Inc. $TVTX Stake Lowered by Universal Beteiligungs und Servicegesellschaft mbH - MarketBeat
How Travere Therapeutics Inc. stock reacts to bond yieldsWeekly Stock Recap & AI Driven Stock Movement Reports - BỘ NỘI VỤ
How Travere Therapeutics Inc. stock trades during market volatilityWeekly Stock Analysis & Safe Entry Trade Reports - moha.gov.vn
Travere Therapeutics: Thriving Kidney Franchise Set To Soar On January PDUFA (TVTX) - Seeking Alpha
Ensign Peak Advisors Inc Increases Stock Holdings in Travere Therapeutics, Inc. $TVTX - MarketBeat
How institutional buying supports Travere Therapeutics Inc. stockMarket Trend Summary & Daily Profit Maximizing Trade Tips - newser.com
Will Travere Therapeutics Inc. stock maintain dividend yieldWeekly Earnings Recap & Real-Time Chart Breakout Alerts - newser.com
Is Travere Therapeutics Inc. stock trading at a premium valuationWeekly Loss Report & AI Driven Price Predictions - newser.com
Is Travere Therapeutics Inc. stock in correction or buying zoneJuly 2025 Fed Impact & Real-Time Chart Pattern Alerts - newser.com
(TVTX) and the Role of Price-Sensitive Allocations - news.stocktradersdaily.com
What makes Travere Therapeutics Inc. stock attractive to growth funds2025 Top Decliners & Expert Approved Trade Ideas - newser.com
What indicators show strength in Travere Therapeutics Inc.July 2025 Price Swings & AI Powered Market Trend Analysis - newser.com
What momentum shifts mean for Travere Therapeutics Inc.2025 Technical Overview & Safe Capital Growth Stock Tips - newser.com
Can Travere Therapeutics Inc. stock deliver strong Q4 earningsPortfolio Risk Report & Weekly Watchlist of Top Performers - newser.com
How Travere Therapeutics Inc. stock compares to industry benchmarksQuarterly Performance Summary & Weekly Breakout Stock Alerts - newser.com
0.36%
1.05%
자본화:
|
볼륨(24시간):